Handbook of Neuroemergency Clinical Trials, 2e focuswa on the "state of the practice" of clinical trials in acute neuroscience populations, or what have been called "neuroemergencies." Neuroemergencies are complex life-threatening diseases and disorders, often with devastating consequences including death or disability. The overall costs are staggering in terms of annual incidence and costs associated with treatment and survival from acute neurological emergencies. Yet, despite their significance as public health issues, there are few drugs and devices available for definitive treatment The book focuses on novel therapies and the unique challenges their intended targets pose for the design and analysis of clinical trials. This volume provides neurologists, neuroscientists, and drug developers with a more complete understanding of the scientific and medical issues of relevance in designing and initiating clinical development plans for novel drugs intended for acute neuroscience populations. The editors provide the best understanding of the pitfalls associated with acute CNS drug development and the best information available regarding how to approach and solve the issues that have plagued drug development. Comprehensive overview on clinical trials and drug development challenges in acute neuroscience populations Provides neurologists, neuroscientists, and drug developers with a complete understanding of scientific and medical issues related to designing clinical trials Edited by leaders in the field who have designed and managed over 50 neuroemergency clinical trials